BioXcel Therapeutics Aktie
WKN DE: A2JF20 / ISIN: US09075P1057
28.02.2025 18:08:21
|
BioXcel Therapeutics Stock Surges 56% After Regaining Nasdaq Compliance
(RTTNews) - BioXcel Therapeutics, Inc. (BTAI) is up 32.91 percent, rising $0.97 to trade at $2.30 after the company announced it has regained compliance with the Nasdaq minimum closing bid price requirement.
The stock opened at $1.95 and has traded between $1.82 and $2.82 today on the Nasdaq. Trading volume has skyrocketed to 80.19 million shares, far exceeding its average of 147,006.
BioXcel's 52-week range is $1.72 to $52.80.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioXcel Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |